Radiometal-labeled agents (non-technetium) for diagnostic imaging

Article Abstract:

Although technetium is the most commonly used radiopharmaceutical for diagnostic purposes, researchers continue to develop other radiometal isotopes that can be used with gamma scintigraphy or PET scanning. These compounds can be used for diagnosing heart disease, brain disease and cancer.

---

(super 99m)Tc-labeled small peptides as diagnostic radiopharmaceuticals

Article Abstract:

Researchers continue to develop target-specific radiopharmaceuticals. Most often, the target is a cell receptor, so radiolabelled peptides must be constructed that bind to the receptor. Research on (super 99m)technetium-labelled peptides is discussed.

---

Potential technetium small molecule radiopharmaceuticals

Article Abstract:

Researchers continue to develop the perfect technetium-based radiopharmaceutical. Technetium-99m is used in 85% of all diagnostic scans done in hospitals.

Similar abstracts:

• Abstracts: Functionalized acenes and heteroacenes for organic electronics. Ambient thin film water on insulator surfaces
• Abstracts: Transition metal-catalyzed carbocyclizations in organic synthesis. 2-furyl phosphines as ligands for transition-metal-mediated organic synthesis
• Abstracts: DNA and RNA synthesis: Antifolates. Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy
• Abstracts: Optical biosensors. Wireless sensor networks and chemo-/biosensing. DNA biosensors and microarrays
• Abstracts: Hetero- and metallasiloxanes derived from silanediols, disilanols, silanetriols, and trisilanols. Comprehensive chemistry of polycarbosilanes, polysilazanes, and polycarbosilazanes as precursors of ceramics

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.